Drug Interactions Exam #01 Flashcards
Acidophilus
Transplant patients on immunosuppressants should avoid probiotics b/c introducing live bacteria into an immunocompromised system.
If taking ABO, probiotic effects will be negated (if susceptible). Recommend starting probiotics at tail end of ABO therapy
Lactobacillus acidophilus is a gram(+) anaerobic rod
Chasteberry (Agnus castus)
Uses:
Menstrual disorders and fertility
MOA:
DA agonist and estrogenic effects
DDI:
Enhances other DA agonist drugs for PD like bromocriptine, pergolide (Permax®), pramipexole (Mirapex®), and ropinirole (Requip®) resulting in too much DA which can cause change in mental status and signs of schizophrenia
Counters other DA antagonist drugs for schizophrenia like olanzapine (Zyprexa®), risperidone (Risperdal®), clozapine (Clozaril®)
Additive with estrogen
Opposes tamoxifen
Alfalfa
Uses: nutrients and vitamins
MOA:
Possible immunostimulation
DDI:
Case report of transplant rejection from immunostimulation
Warfarin - alfalfa is rich in Vit K
Aloe vera
Uses (for oral formulation only):
DM
DDI:
Additive hypoglycemic effect with drugs that lower glucose
Aristolochia (Birthwort)
Uses:
Childbirth panacea, pain and inflammation, snake bites
MOA:
KNOWN NEPHROTOXIN
DDI:
Combined nephrotoxic effects with drugs known to cause harm or that affect renal hemodynamics (NSAIDs, ACE-I, ARB)
Ashwagandha (winter cherry)
Uses:
Sedative, possibly DM
MOA:
Possible BG lowering, thyroid properties
DDI:
Additive effect with levothyroxine
Counter effect with anti-thyroid drugs like propylthiouracil, methimazole (Tapazole®)
Betacarotene (precursor to Vit A)
Uses:
Age-related eye disorders, antioxidant
DDI:
Orlistat (Xenical®) indicated for obesity reduces fat absorption - leads to reduced absorption of fat-soluble vitamins (including betacarotene)
Heavy alcohol use - interferes with conversion of betacarotene to vitamin A via CYP2E1 (competition of induction)
Diminishes effects of increasing HDL in patients on simvastatin + niacin
Bilberry
Uses:
Diarrhea, hemorrhoids, venous insufficiency, GI disorders
MOA: possible anti-platelet activity
DDI:
PD interaction with other antiplatelet or anticoagulant drugs
Ephedra (ma huang)
Banned by the FDA
Uses:
weight loss, stimulant, increased concentration, enhanced athletic performance
MOA: CNS and cardiac stimulant, stimulates uterine contractions, peripheral vasoconstriction
Bitter orange
This was manufacturers response to ephedra ban
Uses:
same as ephedra
MOA:
sympathetic alpha-adrenergic agonist
DDI:
inhibits CY3A4
Black cohosh
Use:
Peri- and post- menopausal Sx. Recent studies show no real benefit.
MOA:
Estrogenic properties
DDI:
Additive estrogenic drugs
Counters anti-estrogenic drugs
Caffeine
Sources of caffeine:
Seeds of guarana, tea leaves, nuts of cola
Metabolized by CYP1A2
DDI: Inhibitors of 1A2 like Fluvoxamine (Luvox®) Cimetidine (Tagamet®) Disulfuram (Antabuse®) Cipro® Norfloxacin Clozapine
ASA - Caffeine increases the AUC, Cmax and rate of absorption of ASA
Adenosine (vasodilator) - caffeine is an adenosine antagonist (vasoconstrictor)
Bitter Orange - increased risk of severe cardiac AE
Cat’s Claw
Use:
dyspepsia, antispasmodic, arthritis, herpes, HIV, and contraceptive
MOA: antiplatelet and antihypertensive effects
DDI:
Potent 3A4 inhibitor
Chamomile
Use:
dyspepsia, travel sickness
MOA:
contains a natural coumarin
DDI:
warfarin - additive effect
Chondrointin
Use:
OA
Structurally similar to heparin so may have additive anticoagulant properties
Coenzyme Q10
Use:
cardiac health, prevent statin-induced myopathy, antioxidant
DDI:
NO clinically significant interaction with warfarin
Cranberry
Use:
urinary antiseptic
DDI:
does NOT affect PK of drugs like cyclosporine or warfarin